News
- Author:
- Ted Bosworth
Publish date: May 18, 2023
Patients in cardiogenic shock should not be excluded from transcatheter aortic valve replacement, despite some early adverse event risk, new regist...
News
- Author:
- Ted Bosworth
Publish date: May 17, 2023
A large transcatheter aortic valve transplant (TAVR) database shows a second procedure performs about as well as native TAVR.
News
- Author:
- Ted Bosworth
Publish date: May 5, 2023
If the goal is not to miss any LVOs, there is no NIHSS score below which these do not occur.
News
- Author:
- Ted Bosworth
Publish date: May 5, 2023
The data support the theory that treatment should begin early in patients with a high likelihood of developing symptomatic MS on the basis of brain...
News
- Author:
- Ted Bosworth
Publish date: May 4, 2023
The experimental device is designed to deliver levodopa and carbidopa into the mouth through a micropump within a wearable retainer.
News
- Author:
- Ted Bosworth
Publish date: April 27, 2023
The model, which is clinically viable even as it is still evolving, predicts disability progression with an accuracy of approximately 70%.
News
- Author:
- Ted Bosworth
Publish date: April 27, 2023
Interim study data showed rapid reductions in multiple biomarkers of muscle injury, reductions in anti-inflammatory markers, proteomic changes cons...
News
- Author:
- Ted Bosworth
Publish date: April 25, 2023
The subcutaneous infusion system improved ON time without troublesome dyskinesias while improving symptoms according to ratings from both patients ...
News
- Author:
- Ted Bosworth
Publish date: April 24, 2023
In the case of persistent neurologic symptoms after COVID, antibodies produced for previously encountered coronaviruses rather than for SARS-CoV2 m...
News
- Author:
- Ted Bosworth
Publish date: March 29, 2023
The co-primary endpoints were change in IGA and EASI scores at 16 weeks, and both improved rapidly, showing statistical significance relative to pl...
News
- Author:
- Ted Bosworth
Publish date: March 27, 2023
The phase 2b data suggest that the drug, called orismilast, “is a potential new addition to the psoriasis armamentarium,” said Lars E. French, MD.<...
News
- Author:
- Ted Bosworth
Publish date: March 24, 2023
Deuruxolitinib (CTP-543), an inhibitor of the JAK1 and JAK2 enzymes, has the potential to become the second JAK inhibitor available for the treatme...
News
- Author:
- Ted Bosworth
Publish date: March 22, 2023
New independent studies support safety of left atrial appendage closure devices in broad array of patient types.
News
- Author:
- Ted Bosworth
Publish date: March 21, 2023
The study drug “is a potent, selective humanized IgG1-neutralizing antibody directed at IFN-beta,” said Dr. Aaron Mangold, the principal investigat...
News
- Author:
- Ted Bosworth
Publish date: March 20, 2023
This clearly validates this target for the control of HS," reported lead investigator Alexa B. Kimball, MD, MPH.
